Contact
searchSearch
HMP Global
Login

Anxiety Disorders Topic Center

A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A person's hands typing on a smartphone
News
Smartphone-Delivered Digital CBT Improves Anxiety Symptoms in Adults
12/29/2025
Sarah Fleming
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital...
12/29/2025
Psych Congress Network
quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network
black and white photo of a man
News
Prenatal Lead Exposure Linked to MDD, Anxiety Symptoms in Later Life
10/28/2025
Maria Mantas
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead,...
10/28/2025
Psych Congress Network
Conference attendees look at a poster
Conference Coverage
Digital Therapeutic Rejoyn May Aid Anxiety in MDD Patients
09/25/2025
Brionna Mendoza
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn...
09/25/2025
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
From Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
From Psych Congress NP Institute
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network

News Articles

A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A person's hands typing on a smartphone
News
Smartphone-Delivered Digital CBT Improves Anxiety Symptoms in Adults
12/29/2025
Sarah Fleming
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital...
12/29/2025
Psych Congress Network
black and white photo of a man
News
Prenatal Lead Exposure Linked to MDD, Anxiety Symptoms in Later Life
10/28/2025
Maria Mantas
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead,...
10/28/2025
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
Jolynn Tumolo
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Neuroactive Nasal Spray Promising Treatment for SAD
News
Neuroactive Nasal Spray Promising Treatment for SAD
12/07/2023
Evi Arthur
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
News
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
11/20/2023
Jolynn Tumolo
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol...
11/20/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
Image of man with neurological issue
News
Anxiety Alters Neural Pathways for Emotional Control, Highlighting Compensatory Mechanisms
08/29/2023
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on...
08/29/2023
Psych Congress Network
spilled bottle of white pills
News
Clozapine Shows Superior Response After First Antipsychotic Failure
03/20/2026
Maria Mantas
Clozapine was more effective than olanzapine and amisulpride in first-episode psychosis (FEP) patients with schizophrenia, schizophreniform, or schizoaffective disorder who did not respond to an initial antipsychotic, according to recent...
Clozapine was more effective than olanzapine and amisulpride in first-episode psychosis (FEP) patients with schizophrenia, schizophreniform, or schizoaffective disorder who did not respond to an initial antipsychotic, according to recent...
Clozapine was more effective...
03/20/2026
Psych Congress Network
a person holds a glass of water and pills
News
Antidepressant Use Patterns May Help Personalize MDD Treatment
03/16/2026
Brionna Mendoza
A new cohort study published in JAMA Psychiatry examined whether real-world antidepressant prescription patterns in MDD patients could help identify biologically meaningful subtypes of depression.
A new cohort study published in JAMA Psychiatry examined whether real-world antidepressant prescription patterns in MDD patients could help identify biologically meaningful subtypes of depression.
A new cohort study published in...
03/16/2026
Psych Congress Network
a man running on a beach
News
Review Urges Greater Exercise Integration in Schizophrenia, SMI Care
03/16/2026
Brionna Mendoza
The integration of physical activity into routine psychiatric care could significantly improve outcomes for people with severe mental illness (SMI), including schizophrenia, according to a narrative review published in JAMA Psychiatry.
The integration of physical activity into routine psychiatric care could significantly improve outcomes for people with severe mental illness (SMI), including schizophrenia, according to a narrative review published in JAMA Psychiatry.
The integration of physical...
03/16/2026
Psych Congress Network
a man sits alone by a lake
News
Loneliness Partially Mediates Link Between Anxiety, Depression, and Suicidal Ideation
03/12/2026
Maria Mantas
Loneliness significantly contributes to the relationship between anxiety symptoms, depressive symptoms, and suicidal ideation among US adults, according to recent analysis findings.
Loneliness significantly contributes to the relationship between anxiety symptoms, depressive symptoms, and suicidal ideation among US adults, according to recent analysis findings.
Loneliness significantly...
03/12/2026
Psych Congress Network
A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
orange pill bottle antidepressant depression major depressive disorder MDD
News
Decision Tool Reduces Antidepressant Dropout in Major Depressive Disorder
03/06/2026
Brionna Mendoza
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support...
03/06/2026
Psych Congress Network
a strand of DNA
News
Copy Number Variant Deletions Linked to Earlier Schizophrenia Onset
03/05/2026
Maria Mantas
Increased copy number variant (CNV) burden, specifically deletions, is associated with earlier age at onset (AAO) of schizophrenia, according to recent research findings.
Increased copy number variant (CNV) burden, specifically deletions, is associated with earlier age at onset (AAO) of schizophrenia, according to recent research findings.
Increased copy number variant...
03/05/2026
Psych Congress Network
an illustration of a man sitting on the ground holding his head with his profile and brain in the background
News
Indirect Costs Drive $366B Schizophrenia Burden in US
02/27/2026
Brionna Mendoza
A comprehensive economic evaluation reported substantial national and state-level societal costs of schizophrenia in the United States for the 2024 calendar year, estimating a total excess societal cost at $366.8 billion.
A comprehensive economic evaluation reported substantial national and state-level societal costs of schizophrenia in the United States for the 2024 calendar year, estimating a total excess societal cost at $366.8 billion.
A comprehensive economic...
02/27/2026
Psych Congress Network
Food and Drug Administration building
News
FDA Approves Milsaperidone for Bipolar I and Schizophrenia in Adults
02/24/2026
Maria Mantas
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved...
02/24/2026
Psych Congress Network
psilocybin-containing mushrooms in a beaker
News
Synthetic Psilocybin Meets Primary Endpoint in Phase 3 Treatment-Resistant Depression Trial
02/19/2026
Maria Mantas
A synthetic form of psilocybin (COMP360) has met the primary endpoint in a second phase 3 trial evaluating its efficacy and safety in patients with treatment-resistant depression (TRD).
A synthetic form of psilocybin (COMP360) has met the primary endpoint in a second phase 3 trial evaluating its efficacy and safety in patients with treatment-resistant depression (TRD).
A synthetic form of psilocybin...
02/19/2026
Psych Congress Network

Interactive Features

quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
How many weeks must separation anxiety symptoms be present to diagnose children?
Quiz
How many weeks must separation anxiety symptoms be present to diagnose children?
11/10/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
11/10/2023
Psych Congress Network
quiz
Quiz
Which symptoms indicate a panic disorder diagnosis?
03/30/2023
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic...
03/30/2023
Psych Congress Network
By how much did deep brain stimulation reduce OCD symptoms?
Quiz
By how much did deep brain stimulation reduce OCD symptoms?
12/12/2022
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/12/2022
Psych Congress Network
Quiz
Quiz
What percent of adults report anxiety relating to their mental health?
01/28/2022
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll,...
01/28/2022
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Intervention in Bulimia Nervosa
02/26/2026
Maria Mantas
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA...
02/26/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Intranasal Esketamine Dosage for Adult MDD
02/04/2026
Brionna Mendoza
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and...
02/04/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Brain Aging in Schizophrenia
01/22/2026
Maria Mantas
Test your knowledge of recent research with this quick quiz!
Test your knowledge of recent research with this quick quiz!
Test your knowledge of recent...
01/22/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet
Guidelines Quiz
Medication Monitoring in Patients With BPD
01/20/2026
Brionna Mendoza
Test your knowledge of APA guidelines with this quiz!
Test your knowledge of APA guidelines with this quiz!
Test your knowledge of APA...
01/20/2026
Psych Congress Network
Mark Olfson, MD, MPH
Quiz
Telemental Health Use Patterns
01/16/2026
Maria Mantas
Are you caught up with the latest research on telehealth use patterns?
Are you caught up with the latest research on telehealth use patterns?
Are you caught up with the...
01/16/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Stimulants and Psychosis Risk in ADHD
12/22/2025
Maria Mantas
Do you remember the findings from this systematic review?
Do you remember the findings from this systematic review?
Do you remember the findings...
12/22/2025
Psych Congress Network
Joseph Goldberg, MD
Quiz
Diagnosing Mixed Features in Bipolar Disorder
12/03/2025
Joseph F. Goldberg, MD
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/03/2025
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Depression, Inflammation, and Insomnia
11/19/2025
Brionna Mendoza
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
11/19/2025
Psych Congress Network
quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network

Blogs
Blog
Reducing the Burden of Generalized Anxiety Disorder
04/14/2021
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from...
04/14/2021
Psych Congress Network
Blog
Are Benzodiazepines the Next Opioid Crisis?
02/19/2019
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published...
02/19/2019
Psych Congress Network
Blog
Psilocybin Studies: A New Ray of Hope for Psychiatry?
12/01/2016
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the...
12/01/2016
Psych Congress Network
Blog
Psychedelics: What to Tell Patients Today
08/25/2015
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are...
08/25/2015
Psych Congress Network
marc agronin md
Faculty Insights
Alzheimer Disease Prevention: Part 2
07/29/2024
Marc E. Agronin, MD
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Marc E. Agronin, MD
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

Posters

Pilot Implementation Of Mindfulness Meditation With Esketamine For Major Depressive Disorder
This project explores the integration of mindfulness meditation with esketamine in the treatment of major depressive disorder. Conducted as a quasi-experimental pilot, the study involved ...
10/17/2025
Retrospective Analysis of Real-World Transition Strategies for Xanomeline and Trospium Chloride in Adult Patients With Schizophrenia
Up to 50% of adults with schizophrenia switch antipsychotic medication within 2 years of treatment initiation. We conducted a real-world analysis of strategies used by healthcare provider...
10/17/2025
Real-World Comparison of Olanzapine/Samidorphan vs Olanzapine: An Assessment of Treatment Patterns and Acute Care Events Among Patients With Bipolar I Disorder
This real-world claims analysis compared combined olanzapine/samidorphan (OLZ/SAM) versus olanzapine in patients with bipolar I disorder. OLZ/SAM was associated with significantly better ...
10/17/2025
Results From a Phase 4, Open-Label, Multicenter, Two-Cohort, Two-Period, Slow-Titration and Food Effect Trial to Assess the Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia
Short description: Prior pharmacokinetic studies of X/T in healthy volunteers showed dosing with food reduced trospium bioavailability, potentially impacting tolerability. This open-label...
10/17/2025
Long-Term Effectiveness With Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) in Adults With Schizophrenia: Results From up to 48 Weeks Open Label Treatment in the Phase 3 SOLARIS Trial
TV-44749 is a once-monthly subcutaneous long-acting injectable olanzapine, designed to provide sustained efficacy without the risk of post-injection delirium/sedation syndrome (PDSS). Her...
10/17/2025
Residual Symptom Burden in Patients With Narcolepsy Satisfied With Treatment: Subgroup Analysis From The CRESCENDO Survey
CRESCENDO was a survey of the patient experience in adults with narcolepsy type 1. This subgroup analysis examined residual symptoms among respondents who reported satisfaction with curre...
10/17/2025
Improvement in Bothersome Mood, Cognitive, and Functional Impacts of Idiopathic Hypersomnia After Low-Sodium Oxybate Treatment in the DUET Study
Jazz DUET (NCT05875974) was a patient-centric, prospective, single-arm, open-label study evaluating effectiveness of low-sodium oxybate (LXB) in IH or narcolepsy. In participants with IH,...
10/17/2025
Neuropsychiatric and Cognitive Sequelae of Severe Hypothyroidism: Insights into Endocrine–Brain Interactions
Severe hypothyroidism can present with predominant psychiatric and cognitive symptoms, making diagnosis challenging when classic somatic signs are absent. This poster explores the neurops...
10/17/2025
Late-Onset Agitated Depression with Anxious and Obsessive Features Triggered by Parental Decline: A Case for Integrated Pharmacology, Neuromodulation, and Psychodynamic Treatments
A 65-year-old male veteran with no prior psychiatric history and a past medical history of seizure disorder developed severe, treatment-resistant depression after witnessing his mother’s ...
10/17/2025
A Conceptual Model For Assessing Psychosocial Functioning In People Living With Schizophrenia
This study developed and refined a conceptual model (CM) to assess psychosocial functioning in people living with schizophrenia (PLS), integrating insights from a targeted literature revi...
10/17/2025

Practice Tools

Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network
Saundra's Corner
Social Phobia Inventory (SPIN)
09/28/2016
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of...
09/28/2016
Psych Congress Network
Saundra's Corner
Mini-Social Phobia Inventory (Mini-SPIN)
09/28/2016
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool...
09/28/2016
Psych Congress Network
Saundra's Corner
Generalized Anxiety Disorder-7 (GAD-7)
09/28/2016
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients...
09/28/2016
Psych Congress Network
Saundra's Corner
Anxiety Disorders
09/28/2016
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety...
09/28/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use